Four major U.S. medical organizations released a coordinated framework on October 26, 2026, establishing a female-specific life course approach to prevent, detect, and manage cardiovascular disease across every biological stage from adolescence onward.
Four Medical Societies Unite to Address Cardiovascular Disease in Women
Cardiovascular disease remains the leading cause of death among women in the United States, claiming more than 400,000 lives annually—a toll exceeding breast cancer, lung cancer, and chronic lung disease combined. Despite these statistics, only about four in 10 women recognize the condition as their greatest health threat. Globally, stroke and heart disease are expected to increase markedly among women over the next twenty years, and although researchers were not mandated to include female participants in cardiac clinical trials until 1993, male participants still outnumber female participants in trials today.
Aiming to reverse twenty years of stagnant progress in stopping female cardiovascular fatalities, the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, the Society for Maternal-Fetal Medicine, and the American Heart Association united. Their consolidated guidance, published in the AHA journal Circulation, outlines how hormonal shifts, reproductive history, and mental well-being intersect with heart health. Because female-specific biology shapes the hearts of girls and women throughout their lives, the coalition maintains that comprehensive, continuous care must begin in adolescence to address life transitions absent from the male-centric frameworks that currently dominate healthcare.
Women experience their healthcare across clinical specialties, but it often is fragmented or disconnected.
Sadiya Khan
Life Stage Framework Connects Puberty and Postmenopause to Heart Risk
The newly established Female Life Stage framework divides a woman’s biological timeline into distinct phases, beginning in pediatrics. The framework evaluates perimenarche between ages 8 and 15, noting that heavy or irregular menstrual bleeding can signal underlying conditions like polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS). Experiencing a first period before age 10 is linked to an elevated risk of heart disease later in life. For girls roughly between 8 and 15 years old, heart health evaluations may involve measuring fatty compounds or lipids, checking blood pressure and body mass index on a yearly basis, and assessing glucose levels.
During reproductive years spanning ages 15 to 44, regular ovarian cycling and pregnancies occur. Dr. Molly Siegel, medical director of obstetrics and gynecology at Mass General Health Centers, notes that pregnancy functions as a natural stress test for the cardiovascular system. Complications such as gestational diabetes, high blood pressure, preeclampsia, preterm birth, and stillbirth expose underlying cardiovascular risks that require long-term tracking rather than dismissal once delivery concludes. Only about 60 percent of U.S. women experiencing hypertensive pregnancy complications receive follow-up blood pressure care within six months of delivery.
Evaluate Cardiovascular Risks During Metabolic Transitions
As women enter perimenopause and postmenopause, metabolic changes accelerate. Postmenopause officially begins 12 months after the final menstrual period and accounts for up to 40 percent of a woman’s life. While more than 80 percent of strokes, heart failure events, and heart attacks occurring during this stage can be prevented with early action, traditional risk calculators often fail to capture female-specific variables. Women approximately 45 years of age and older should undergo evaluations for these identical markers, taking into account how the menopausal transition can quicken the growth of cardiovascular disease risk via metabolic and vascular shifts driven by changing hormone levels and ovarian aging.
Writing for Katie Couric Media, board-certified OB-GYN Sarah Berg emphasizes that the age at which menopause occurs serves as a critical diagnostic question. Reaching menopause before age 40 elevates cardiovascular disease risk by about 55 percent, while menopause between ages 40 and 44 raises it by approximately 30 percent. Having both ovaries removed before age 40 carries even more risk than reaching menopause that early on its own. Dr. Roy Jogiya, chief medical advisor at Heart Research UK, told Fit&Well that symptoms like new chest discomfort resembling indigestion, unexplained breathlessness during routine tasks, and reduced exercise tolerance demand immediate medical evaluation rather than automatic attribution to hormonal changes.
Specifically, these reports connect the dots for clinicians, for patients, and across health domains so that care is holistic and begins in adolescence, recognizing that women’s heart health is uniquely shaped by biological transitions not experienced by men — periods, pregnancy, perimenopause, and menopause.
Mariell Jessup, chief science and medical officer of the American Heart Association
The four medical organizations urge clinicians across pediatrics, obstetrics, gynecology, and cardiology to use shared risk equations, ensuring patients manage lifetime healthcare transitions with a unified medical record. To prevent pediatricians, gynecologists, obstetricians, and cardiologists from working in isolation, the groups also advocate for establishing a national network dedicated to centers of excellence in women’s cardiac care.